Pfizer's animal health unit Zoetis sets terms for $2-billion IPO

Zoetis, the Pfizer animal health medicines and vaccines unit, on Thursday announced terms for its previously reported initial public offering of shares (IPO). The company plans to raise about $2.2 billion by offering 86.1 million shares at a price range of $22.00 to $25.00. At the midpoint of the proposed range, Zoetis would command a fully diluted market value of $11.8 billion. Zoetis, which was founded in 2012 and reported $4.3 billion in sales for the 12 months ended 30 September 2012, plans to list on the New York Stock Exchange under the symbol ZTS. J.P...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers